(Q36577606)

15 August 2017

1 reference

title

FGF23: its role in renal bone disease (English)

1 reference

15 August 2017

Masafumi Fukagawa

1

1 reference

PubMed ID

16932898

15 August 2017

Junichiro James Kazama

series ordinal

2

1 reference

15 August 2017

24 August 2006

1 reference

15 August 2017

1 reference

15 August 2017

21

1 reference

15 August 2017

12

1 reference

15 August 2017

1802-1806

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-006-0230-3

15 August 2017

0 references

cites work

Mechanisms of secondary hyperparathyroidism

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00467-006-0230-3

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

21 January 2018

1 reference

12 December 2020

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

1 reference

12 December 2020

Serum FGF23 levels in normal and disordered phosphorus homeostasis.

1 reference

12 December 2020

Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23

1 reference

12 December 2020

Uremic bone disease: advances over the last 30 years

1 reference

12 December 2020

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

1 reference

12 December 2020

Bone as a source of FGF23: regulation by phosphate?

1 reference

12 December 2020

Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis

1 reference

12 December 2020

"Phosphatonins" and the regulation of phosphorus homeostasis

1 reference

12 December 2020

A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis

1 reference

12 December 2020

Fibroblast growth factor 23: roles in health and disease

1 reference

12 December 2020

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

1 reference

12 December 2020

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients

1 reference

12 December 2020

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

1 reference

12 December 2020

Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.

1 reference

12 December 2020

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

12 December 2020

Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia

1 reference

12 December 2020

Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism

1 reference

12 December 2020

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

1 reference

12 December 2020

Klotho, an important new factor for the activity of Ca2+ channels, connecting calcium homeostasis, ageing and uraemia

1 reference

12 December 2020

1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport

1 reference

12 December 2020

Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.

1 reference

12 December 2020

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

1 reference

12 December 2020

Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

1 reference

12 December 2020

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro

1 reference

12 December 2020

Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism

1 reference

12 December 2020

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

1 reference

12 December 2020

On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake

1 reference

12 December 2020

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

12 December 2020

Regulation of fibroblast growth factor-23 signaling by klotho

1 reference

12 December 2020

Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells

1 reference

12 December 2020

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

1 reference

12 December 2020

Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats

1 reference

12 December 2020

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

12 December 2020

Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients

1 reference

12 December 2020

Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23.

1 reference

12 December 2020

Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism

1 reference

12 December 2020

Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice

1 reference

12 December 2020

Comparison of two assays for fibroblast growth factor (FGF)-23

1 reference

12 December 2020

Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed.

1 reference

12 December 2020

FGF-23 in patients with end-stage renal disease on hemodialysis

1 reference

12 December 2020

FGF-23, vitamin D and calcification: the unholy triad

1 reference

12 December 2020

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

1 reference

12 December 2020

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

1 reference

12 December 2020

Vascular calcification in chronic kidney disease

1 reference

12 December 2020

Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

10.1007/S00467-006-0230-3

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16932898